National and Kapodistrian University of Athens
Development and validation of molecular assays for gene expression and DNA mutations in liquid biopsy samples
Abstract
dc:descriptionMolecular analysis in liquid biopsy samples requires the development of methodologies with high specificity and sensitivity in order to overcome the limitations and challenges. Here, in this PhD thesis, new methodologies with highly sensitive technologies were developed and validated in liquid biopsy samples. 1) We evaluated the performance of a novel multiplex assay for the detection of ten ESR1 mutations and AKT1 E17K in plasma-cell free DNA (cfDNA) based on Crystal Digital PCR®. Towards this, we analyzed in parallel identical plasma-cfDNA samples for ESR1 mutations with the multiplex Crystal Digital PCR® assay and the ESR1-NAPA assay and compared directly the results. 2) We investigated whether analysis of ESR1 mutations in circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) provide complementary information on resistance to endocrine therapy. Using a highly sensitive multiplex ddPCR assay, we detected a higher percentage of mutations in CTC-derived genomic (gDNAs) than in paired ctDNA in patients with metastatic breast cancer. 3) We conducted a study to directly compare our ultrasensitive real-time PCR assay based on the combination of ARMS-PCR for the detection of PIK3CA p.E545K, p.E542K, p.H1047R mutations with ddPCR in primary tumors and plasma-cfDNA, and directly compare the PIK3CA mutational status in CTC-derived gDNAs and paired plasma-cfDNA samples. 4) A new method was evaluated that uses ultraviolet light to eliminate wild-type (wt-DNA) alleles and enables improved detection of minor genetic or epigenetic changes. PD-UVME employed oligonucleotide probes that incorporated a photosensitive 3-cyanovinylcarbazole nucleoside (CNVK), placed directly opposite interrogated pyrimidines, such as thymine or cytosine in wt-DNA. PD-UVME was combined with ddPCR to detect BRAF V600E mutation in model systems, thyroid patient cancer tissue samples, and ctDNA from melanoma patients. 5) We conducted a study to develop and validate a novel RT-qPCR assay for CTLA-4 transcripts and study the expression of CTLA-4 in CTCs of patients with metastatic cancer under immunotherapy.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Smilkou, Stavroula
- Σμίλκου, Σταυρούλα
Subjects
dc:subject × 16- Υγρή βιοψία
- Κυκλοφορούντα καρκινικά κύτταρα
- Kυκλοφορούν καρκινικό DNA
- Μεταλλάξεις DNA
- Γονιδιακή έκφραση
- Liquid biopsy
- Circulating tumor cells (CTCs)
- Circulating tumor DNA (ctDNA)
- DNA mutations
- Gene expression
- Χημεία
- Φυσικές Επιστήμες
- Αναλυτική χημεία
- Chemical Sciences
- Natural Sciences
- Analytical Chemistry
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58080